Illumina is an American company. Incorporated on April 1, 1998. Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Goldman Sachs is forecasting the S&P500 index to climb 9% to 5100 by year-end. David Koslin says that ‘profit growth has accounted for the entire S&P500 return in 2021 and will continue to drive gains in 2022’.
Over the last 10 years, Illumina has risen 80% of the time between November 16 and January 11 with an average return of 10.06%. The largest gain was last year with a whopping 25.53% rise. The largest loss was in 2018 where Illumina registered a -4.02% loss.
Major Trade Risks: A move towards earlier interest rates from the Fed will change this outlook as well any strong risk-off trading.